Generic placeholder image

Current Drug Targets - CNS & Neurological Disorders

Editor-in-Chief

ISSN (Print): 1568-007X
ISSN (Online): 1568-007X

Cholesterol and Apoe: A Target for Alzheimers Disease Therapeutics

Author(s): Daniela Fenili and JoAnne McLaurin

Volume 4 , Issue 5 , 2005

Page: [553 - 567] Pages: 15

DOI: 10.2174/156800705774322085

Price: $65

Abstract

Alzheimers disease (AD) is a debilitating disease that affects many people. In order to reduce the number of people diagnosed with this disease, drug strategies need to be implemented that target early steps in disease pathogenesis. Elevated cholesterol levels and presence of the apolipoprotein E 4 allele increase AD risk. How these two factors may contribute to AD pathogenesis and some therapeutic strategies for alleviating AD risk will be discussed.

Keywords: alzheimers disease, cholesterol, apoe, statins, membrane fluidity, fibrillogenesis


Rights & Permissions Print Export Cite as
© 2022 Bentham Science Publishers | Privacy Policy